Logo

EyePoint Pharmaceuticals, Inc.

EYPT

EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intravitreal implant for intravitreal injection for the tre… read more

Healthcare

Biotechnology

21 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$12.42

Price

+1.39%

$0.17

Market Cap

$1.041b

Small

Price/Earnings

-

Premium

3y Avg

Premium

5y Avg

Financial Reports

Key metrics over the past few years and other important metrics. Amounts in USD.

-12104.3%

EBITDA Margin

-12188.5%

Net Profit Margin

-11716.4%

Free Cash Flow Margin

-12104.3%

EBITDA Margin

-12188.5%

Net Profit Margin

-11716.4%

Free Cash Flow Margin
Revenue

$7.615m

-75.7%

1y CAGR

-36.4%

3y CAGR

-24.5%

5y CAGR
Earnings

-$271.599m

-17.1%

1y CAGR

-59.7%

3y CAGR

-37.1%

5y CAGR
EPS

-$3.50

-10.4%

1y CAGR

-24.8%

3y CAGR

-10.2%

5y CAGR
Book Value

$230.472m

$288.217m

Assets

$57.745m

Liabilities

$22.314m

Debt
Debt to Assets

7.7%

-0.1x

Debt to EBITDA
Free Cash Flow

-$271.540m

-11.6%

1y CAGR

-2700.1%

3y CAGR

-2000.7%

5y CAGR
No items found.
Press Releases
Statements and updates from the company
↑ TopSummaryPriceFinancialsPress Releases